The Coalition and American Hospital Association, AdventHealth, Atalan, and Providence’s Well Being Trust collaborate on practical framework for healthcare initiative evaluation ALTAMONTE SPRINGS, Fla., July 15, 2026 (GLOBE NEWSWIRE) -- The Coalition for Physician & APP Well-Being, a non-profit entity comprised of national healthcare organizations dedicated to fostering the well-being…
Read More
PHILADELPHIA, June 25, 2026 (GLOBE NEWSWIRE) -- Nurse burnout remains a significant challenge in the healthcare industry, with growing interest in tools that can help identify retention risk earlier. Atalan for Nursing is intended to address this need. Atalan, the leading Clinician Retention Intelligence (CRI) platform, today announced the launch…
Read More
BCI’s second investment to advance therapeutic treatments for celiac disease will support preclinical development of novel approach to immune tolerance AMBLER, PA, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- Beyond Celiac Investments (BCI), the venture philanthropy program of Beyond Celiac, today announced an investment in Tolerance Bio Inc., to support…
Read More
Established biopharmaceutical executive with more than 25 years of business development, corporate strategy, financing, and transaction experience Demonstrated leader in gene therapy and CNS drug development Appointment comes as Latus enters the clinic, with LTS-201 for Huntington’s disease on track for IND submission in 3Q 2026 PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus…
Read More
Elsevier's ClinicalKey Al and Wei/sheet will deliver verifiable clinical evidence and patient context directly into the EHR, giving clinicians governed Al answers within their existing workflows NEW YORK, June 3, 2026 /PRNewswire/ -- Elsevier today announced it has acquired Wellsheet, a US-based health technology company that specializes in aggregating and…
Read More
lmmuno-oncology leader brings more than three decades of experience advancing innovative cancer therapies across biotech, pharma, and the National Cancer Institute HOUSTON, May 28, 2026 /PRNewswire/ -- lmmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced the appointment of Claudio Dansky Ullmann, M.D. as Chief Medical Officer. Dr…
Read More
Computational and preclinical data support advancement of LTS-201 and LTS-101 programs into clinic later this year Latus founder Beverly Davidson, Ph.D., awarded the ASGCT Outstanding Achievement Award – the Society’s highest honor PHILADELPHIA & BOSTON--(BUSINESS WIRE)--Latus Bio, Inc. (Latus), a company advancing scalable genetic medicines for broad patient populations, today…
Read More
The Economic Times, US Story by Maitreyee Thakkar, Global Desk For decades, advances in battlefield medicine have focused on one goal: keep the wounded alive long enough to reach a surgical facility. Tourniquets, hemostatic dressings, rapid evacuation, and forward surgical teams dramatically improved survival in Iraq and Afghanistan. Yet one…
Read More
The acquisition brings together the gold standard for continuous ambulatory cough monitoring and lung sound analysis with proven remote spirometry and FeNO capabilities - creating a unique, single-partner endpoint solution for respiratory sponsors. PHILADELPHIA, PA / ACCESS Newswire / April 16, 2026 / Strados Labs, the respiratory endpoint intelligence company, today announced the…
Read More
Presentation details the IND-enabling work for IMGS-203, a potent Stimulator of Interferon Genes (STING) Agonist, for the treatment of Glioblastoma Multiforme (GBM) Houston, Texas, April 15, 2026 /PR Newswire/— ImmunoGenesis, a clinical-stage biotech company developing innovative, science-driven immunotherapies, today announced that it will present a poster at the upcoming American…
Read More